These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33553151)

  • 1. A Novel m
    Chen S; Zhang N; Zhang E; Wang T; Jiang L; Wang X; Zheng J
    Front Cell Dev Biol; 2020; 8():616972. PubMed ID: 33553151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
    Ma T; Wang X; Wang J; Liu X; Lai S; Zhang W; Meng L; Tian Z; Zhang Y
    Front Genet; 2021; 12():726369. PubMed ID: 34721523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
    Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
    Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
    Zhang L; Su Z; Hong F; Wang L
    Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
    Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
    Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a m
    Chen J; Yu K; Zhong G; Shen W
    Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
    Chen S; Zhang N; Jiang L; Gao F; Shao J; Wang T; Zhang E; Yu H; Wang X; Zheng J
    Int J Cancer; 2021 Feb; 148(3):780-790. PubMed ID: 32895914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine methylation related immune biomarkers correlates with clinicopathological characteristics and prognosis in clear cell renal cell carcinoma.
    Huang Z; Kang W; Zhang Q
    Transl Cancer Res; 2022 Jun; 11(6):1576-1586. PubMed ID: 35836532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic signature predicts overall survival clear cell renal cell carcinoma.
    Wang Y; Chen L; Ju L; Qian K; Wang X; Xiao Y; Wang G
    Cancer Cell Int; 2020 Nov; 20(1):564. PubMed ID: 33292239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 12. Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation.
    Lu W; Che X; Qu X; Zheng C; Yang X; Bao B; Li Z; Wang D; Jin Y; Wang Y; Xiao J; Qi J; Liu Y
    Front Cell Dev Biol; 2021; 9():622198. PubMed ID: 33681201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
    Front Oncol; 2020; 10():788. PubMed ID: 32528886
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic Value of an m
    Li H; Jiang H; Huang Z; Chen Z; Chen N
    Cancer Manag Res; 2021; 13():6673-6687. PubMed ID: 34471382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
    Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
    Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtypes of m
    Guan B; Ren F; Shan W; Zhang S
    Transl Cancer Res; 2022 Mar; 11(3):508-518. PubMed ID: 35402182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma.
    Wang S; Chai K; Chen J
    Oncol Lett; 2019 Dec; 18(6):6605-6613. PubMed ID: 31788117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
    Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
    Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.